Direkt zum Inhalt
Merck
  • Inhibitory effect of ATP analogs and actin on the modification of myosin subfragment 1 with 9-anthroylnitrile.

Inhibitory effect of ATP analogs and actin on the modification of myosin subfragment 1 with 9-anthroylnitrile.

Biochimica et biophysica acta (2004-05-26)
Barbara Pliszka, Emilia Karczewska
ZUSAMMENFASSUNG

The fluorescent probe, 9-anthroylnitrile (ANN), can selectively attach to Ser-180 at the ATP-binding site of subfragment 1 (S1) of skeletal muscle myosin [J. Biol. Chem. 278 (2003) 31891]. We have found that MgATP, MgATPgammaS, MgADP.AlF(4) or MgPP(i), but not MgADP, inhibit the incorporation of ANN into S1. The inhibitory effect of the nucleotide gamma-phosphate group (or its analog) on the modification of S1 with ANN can be explained by the contribution of Ser-180 to the binding of the nucleotide gamma-phosphate at the active site of S1. We have also observed that the incorporation of ANN into S1.MgADP complex is inhibited by actin. These experimental data strongly support the existence of nucleotide-promoted conformational changes revealed by crystal structures of S1 complexes with various nucleotide analogs. They also convincingly show an effect of actin on the environment of Ser-180 at the nucleotide binding site of S1.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
9-Anthracencarbonitril, 97%